tiprankstipranks
Trending News
More News >
Vistagen Therapeutics Inc. (VTGN)
:VTGN
US Market

VistaGen Therapeutics (VTGN) Income Statement

Compare
1,169 Followers

VistaGen Therapeutics Income Statement

Last quarter (Q2 2026), VistaGen Therapeutics's total revenue was $258.00K, an increase of 40.98% from the same quarter last year. In Q2, VistaGen Therapeutics's net income was $-19.42M. See VistaGen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 486.00K$ 1.06M$ -227.00K$ 1.11M$ 1.09M
Gross Profit
$ 486.00K$ 1.06M$ -227.00K$ 1.11M$ 1.09M
Operating Expenses
$ 56.46M$ 34.09M$ 59.04M$ 48.89M$ 19.02M
Depreciation and Amortization
$ 635.00K$ 568.00K$ 532.00K$ 711.10K$ 477.60K
EBITDA
$ -55.34M$ -32.45M$ -58.74M$ -47.05M$ -17.44M
Operating Income
$ -55.97M$ -33.02M$ -59.27M$ -47.78M$ -17.93M
Other Income/Expenses
$ 4.56M$ 3.66M$ 26.00K$ 19.90K$ 2.20K
Pretax Income
$ -51.41M$ -29.36M$ -59.24M$ -47.76M$ -17.93M
Net Income
$ -51.42M$ -29.36M$ -59.25M$ -47.76M$ -17.93M
Per Share Metrics
Basic EPS
$ -1.67$ -1.52$ -8.51$ -7.38$ -14.74
Diluted EPS
$ -1.67$ -1.52$ -8.51$ -7.38$ -14.74
Weighted Average Shares Outstanding
30.71M 19.35M 6.96M 6.60M 2.87M
Weighted Average Shares Outstanding (Diluted)
30.71M 19.35M 6.96M 6.60M 2.87M
Currency in USD

VistaGen Therapeutics Earnings and Revenue History